Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
Submitted by
admin
on June 6, 2010 - 11:03am
Source:
Seeking Alpha
News Tags:
RSV
AstraZeneca
MedImmune
motavizumab
Axanum
Headline:
FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
Do Not Allow Advertisers to Use My Personal information
